Anti-HIV microbicides: don't forget basic immunology

Lancet

Volumn 369, Issue 9571, 2007, Pages 1429-

  Silverstein, Gerry ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE SULFATE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MICROBICIDE; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTING CELL; GENETIC ENGINEERING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOLOGY; INFLAMMATORY CELL; LETTER; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE CULTURE; VAGINA; VIRUS ISOLATION;

EID: 34247385791     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60665-5     Document Type: Letter

References (2)

1. Balzarini J., and Van Damme L. Microbicide drug candidates to prevent HIV infection. Lancet 369 (2007) 787-797
2. Altman L. Tests of drug to block HIV infection are halted over safety. New York Times (Feb 1, 2007)